Phase Ib / Regorafenib With Conventional Chemotherapy/Newly Diagnosed Patients/ Multimetastatic Ewing Sarcoma
Clinical trial NCT05830084 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05830084
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-16
- Primary completion
- 2027-04-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.